Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Julia Wattacheril

doi:10.1016/j.gtc.2019.10.002

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Gastroenterol Clin North Am. 2020 Mar;49(1):141-149. doi: 10.1016/j.gtc.2019.10.002. Epub 2019 Dec 24.

Author

Julia Wattacheril¹

Affiliation

¹ Center for Liver Disease and Transplantation, Columbia University Irving Medical Center - NY Presbyterian Hospital, 622 West 168th Street, PH 14-105D, New York, NY 10032, USA. Electronic address: jjw2151@cumc.columbia.edu.

PMID: 32033760
DOI: 10.1016/j.gtc.2019.10.002

Abstract

Nonalcoholic fatty liver disease (NAFLD) represents a global public health burden. NAFLD, while strongly associated with the metabolic syndrome, can occur independently from existing metabolic diseases. In addition to liver-related disease burden and mortality, significant extrahepatic disease outcomes coexist with NAFLD, including cardiovascular diseases, chronic kidney disease, and type 2 diabetes. Management of these comorbidities contributes to the overall public health burden of NAFLD. These extrahepatic manifestations require healthcare interventions that are vigilant in monitoring for progression of liver disease while simultaneously managing overall morbidity and mortality from other organ systems.

Keywords: CKD; Cardiovascular; Diabetes; Extrahepatic; Fatty liver; Heart failure.

Publication types

Review

MeSH terms

Non-alcoholic Fatty Liver Disease* / pathology
Non-alcoholic Fatty Liver Disease* / physiopathology